Insider Trading activities of Dexcom Inc (DXCM)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc (DXCM) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. Table 2 shows the detailed insider transactions of Dexcom Inc since 2005. The reporting company's ticker symbol is DXCM. The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $6,467,394.
The total value of stock sales since 2005 is $661,615,165.
The total value of stock option exercises since 2005 is $35,809,495.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dexcom Inc (DXCM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 0 $0 11,208 $1,799,610 0 $0
2019-10 0 $0 15,565 $2,336,109 0 $0
2019-09 0 $0 98,366 $14,827,582 0 $0
2019-08 0 $0 19,259 $3,178,154 0 $0
2019-07 0 $0 10,516 $1,564,124 0 $0
2019-06 0 $0 34,694 $4,601,529 0 $0
2019-05 0 $0 21,887 $2,578,675 0 $0
2019-04 0 $0 15,512 $1,828,837 4,797 $34,874
2019-03 0 $0 116,637 $16,625,238 0 $0
2019-02 0 $0 16,535 $2,429,979 0 $0
2019-01 0 $0 22,645 $3,171,079 25,806 $118,191
2018-12 0 $0 21,186 $2,520,068 11,162 $51,121
2018-11 0 $0 36,219 $5,186,854 11,161 $51,117
2018-10 0 $0 23,911 $3,034,722 11,161 $51,117
2018-09 0 $0 136,538 $19,633,675 26,161 $139,917
2018-08 0 $0 79,067 $10,060,102 31,738 $144,845
2018-07 0 $0 34,914 $3,501,714 0 $0
2018-06 0 $0 91,774 $8,697,276 0 $0
2018-05 0 $0 104,458 $8,971,469 106,451 $720,008
2018-04 0 $0 12,581 $919,060 0 $0
2018-03 0 $0 12,581 $831,763 0 $0
2018-02 0 $0 11,638 $651,352 0 $0
2018-01 0 $0 11,635 $657,973 0 $0
2017-12 0 $0 10,880 $643,989 0 $0
2017-11 35,000 $1,746,350 28,525 $1,615,640 0 $0
2017-10 0 $0 1,635 $73,274 0 $0
2017-09 0 $0 12,329 $865,783 0 $0
2017-08 0 $0 14,866 $1,072,656 0 $0
2017-07 0 $0 10,650 $760,867 0 $0
2017-06 0 $0 13,837 $998,052 0 $0
2017-05 0 $0 16,481 $1,137,953 33,649 $237,574
2017-04 0 $0 32,832 $2,469,199 10,000 $87,899
2017-03 0 $0 95,976 $7,455,791 52,390 $404,789
2017-02 0 $0 42,615 $3,412,745 34,627 $326,393
2017-01 0 $0 84,031 $6,496,372 77,837 $662,044
2016-12 0 $0 15,624 $1,002,531 10,000 $76,100
2016-11 0 $0 16,899 $1,161,177 0 $0
2016-10 0 $0 47,510 $3,927,959 11,000 $83,930
2016-09 0 $0 125,242 $11,708,480 16,999 $107,506
2016-08 0 $0 328,552 $29,928,996 87,004 $696,904
2016-07 0 $0 93,885 $7,818,709 42,000 $276,060
2016-06 0 $0 368,568 $27,559,316 180,000 $620,200
2016-05 0 $0 99,002 $6,242,405 20,000 $196,000
2016-04 0 $0 63,971 $4,468,386 20,000 $155,800
2016-03 0 $0 38,696 $2,392,252 0 $0
2016-02 0 $0 3,560 $222,500 0 $0
2016-01 0 $0 33,295 $2,530,624 0 $0
2015-12 0 $0 85,119 $7,185,230 59,000 $407,960
2015-11 0 $0 256,142 $21,784,051 211,001 $1,638,808
2015-10 0 $0 50,420 $4,058,170 20,000 $196,000
2015-09 0 $0 247,099 $23,468,733 190,000 $1,283,223
2015-08 0 $0 145,601 $13,755,602 48,392 $390,485
2015-07 0 $0 176,661 $14,537,192 70,000 $705,930
2015-06 0 $0 175,552 $12,785,157 106,316 $744,932
2015-05 0 $0 371,989 $25,494,868 245,640 $1,461,838
2015-04 0 $0 166,448 $11,174,822 114,758 $1,498,909
2015-03 0 $0 186,159 $11,278,347 122,283 $1,445,564
2015-02 0 $0 79,253 $4,928,395 62,327 $569,108
2015-01 0 $0 119,210 $7,008,248 102,284 $967,219
2014-12 0 $0 159,079 $8,658,835 120,750 $833,925
2014-11 0 $0 375,636 $19,543,412 364,308 $3,158,163
2014-10 0 $0 100,400 $4,117,198 88,750 $639,845
2014-09 0 $0 100,518 $4,179,277 94,250 $600,715
2014-08 0 $0 473,494 $21,016,505 412,520 $3,031,108
2014-07 0 $0 130,500 $4,917,044 88,750 $602,365
2014-06 0 $0 164,500 $6,382,583 92,750 $621,665
2014-05 0 $0 134,957 $3,892,614 96,957 $513,161
2014-04 0 $0 129,884 $4,743,973 100,311 $600,512
2014-03 0 $0 448,985 $20,563,258 443,677 $3,670,026
2014-02 0 $0 280,925 $12,452,842 220,925 $1,592,280
2014-01 0 $0 93,000 $3,406,019 83,000 $578,470
2013-12 0 $0 210,130 $7,162,226 246,090 $1,456,943
2013-11 0 $0 197,322 $6,463,260 154,522 $690,993
2013-10 0 $0 9,000 $251,910 0 $0
2013-09 0 $0 9,000 $243,000 0 $0
2013-08 0 $0 9,000 $199,350 0 $0
2013-07 0 $0 9,000 $205,812 0 $0
2013-06 0 $0 46,361 $1,011,909 10,000 $24,000
2013-05 0 $0 60,272 $1,149,340 50,000 $123,950
2013-04 0 $0 9,000 $152,118 0 $0
2013-03 70,000 $1,085,000 58,070 $928,445 15,416 $7,708
2013-02 0 $0 75,000 $1,123,300 75,000 $239,250
2013-01 0 $0 9,000 $125,010 0 $0
2012-12 0 $0 68,347 $956,515 10,000 $31,900
2012-11 0 $0 5,000 $63,800 0 $0
2012-10 0 $0 5,000 $74,650 0 $0
2012-09 0 $0 24,000 $323,400 0 $0
2012-08 0 $0 36,249 $462,967 0 $0
2012-07 0 $0 5,000 $65,155 0 $0
2012-06 0 $0 17,077 $182,818 0 $0
2012-05 0 $0 19,198 $198,227 28,466 $14,233
2012-04 0 $0 5,000 $53,175 0 $0
2012-03 2,000 $20,710 5,000 $51,550 0 $0
2012-02 0 $0 5,000 $58,545 0 $0
2012-01 0 $0 5,000 $47,650 0 $0
2011-12 2,000 $16,068 0 $0 0 $0
2011-11 8,000 $56,760 0 $0 0 $0
2011-09 2,000 $24,708 0 $0 0 $0
2010-11 2,400 $28,449 0 $0 0 $0
2010-06 5,000 $50,250 0 $0 0 $0
2010-05 65,000 $690,779 0 $0 6,606 $46,109
2010-03 0 $0 10,000 $97,920 0 $0
2009-11 20,000 $143,768 0 $0 0 $0
2009-10 0 $0 0 $0 3,861 $24,440
2009-08 5,000 $34,225 0 $0 0 $0
2009-05 27,500 $103,660 0 $0 0 $0
2009-03 70,800 $285,075 0 $0 0 $0
2008-11 188,750 $336,279 0 $0 0 $0
2008-08 10,000 $66,700 0 $0 0 $0
2008-03 247,000 $1,205,523 0 $0 0 $0
2007-08 0 $0 3,296 $23,401 0 $0
2007-03 0 $0 4,000 $28,700 0 $0
2006-12 0 $0 17,363 $203,164 0 $0
2006-07 3,000 $33,600 0 $0 0 $0
2006-06 0 $0 0 $0 53,125 $21,250
2006-05 0 $0 3,482,500 $83,580,000 172,500 $56,500
2006-03 0 $0 40,648 $748,424 46,614 $23,307
2006-02 0 $0 0 $0 14,375 $4,312
2006-01 0 $0 0 $0 100,000 $50,000
2005-12 0 $0 4,000 $58,348 0 $0
2005-11 0 $0 2,333,900 $31,053,551 0 $0
2005-10 0 $0 611,000 $7,362,550 0 $0
2005-08 9,950 $101,490 0 $0 0 $0
2005-04 36,500 $438,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dexcom Inc insiders (DXCM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-07 Augustinos Nicholas (Director) Sale 1,208 185.29 223,830
2019-11-04 Sayer Kevin R (President, CEO and Chairman) Sale 10,000 157.58 1,575,780
2019-10-23 Doubleday Richard (EVP Chief Commercial Officer) Sale 1,533 152.59 233,912
2019-10-23 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 1,532 152.58 233,757
2019-10-01 Sayer Kevin R (President, CEO and Chairman) Sale 10,000 149.50 1,495,050
2019-10-01 Altman Steven R (Director) Sale 2,500 149.36 373,390
2019-09-24 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 155.19 312,859
2019-09-23 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 1,532 155.63 238,423
2019-09-18 Balo Andrew K (*) Sale 2,386 151.46 361,383
2019-09-16 Augustinos Nicholas (Director) Sale 1,208 145.49 175,751
2019-09-10 Blackford Quentin S. (EVP Chief Financial Officer) Sale 10,320 141.94 1,464,872
2019-09-09 Leach Jacob Steven (EVP Chief Technology Officer) Sale 4,712 147.77 696,273
2019-09-09 Murphy Patrick Michael (SVP Legal Affairs) Sale 2,495 147.79 368,743
2019-09-09 Blackford Quentin S. (EVP Chief Financial Officer) Sale 11,686 147.78 1,726,992
2019-09-09 Ace Heather S (SVP Human Resources) Sale 6,415 153.79 986,594
2019-09-09 Abbey Donald (EVP Quality and Regulatory Aff) Sale 5,843 147.75 863,309
2019-09-09 Doubleday Richard (EVP Chief Commercial Officer) Sale 5,843 147.75 863,274
2019-09-09 Moy Jeffrey (SVP Operations) Sale 4,601 147.74 679,742
2019-09-09 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 5,843 147.78 863,507
2019-09-09 Balo Andrew K (*) Sale 9,107 153.82 1,400,856
2019-09-09 Sayer Kevin R (President, CEO and Chairman) Sale 14,322 147.79 2,116,634
2019-09-03 Balo Andrew K (*) Sale 37 170.00 6,290
2019-09-03 Sayer Kevin R (President, CEO and Chairman) Sale 10,000 170.21 1,702,080
2019-08-23 Ace Heather S (SVP Human Resources) Sale 7,243 175.16 1,268,669
2019-08-23 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 175.22 353,235
2019-08-15 Sayer Kevin R (President, CEO and Chairman) Sale 10,000 155.62 1,556,250
2019-07-23 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 153.69 309,828
2019-07-08 Sayer Kevin R (President, CEO and Chairman) Sale 6,000 145.87 875,244
2019-07-01 Altman Steven R (Director) Sale 2,500 151.62 379,052
2019-06-24 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 150.05 302,496
2019-06-24 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 3,116 150.25 468,172
2019-06-14 Augustinos Nicholas (Director) Sale 1,208 146.32 176,754
2019-06-13 Leach Jacob Steven (EVP Chief Technology Officer) Sale 5,099 145.74 743,148
2019-06-10 Murphy Patrick Michael (SVP Legal Affairs) Sale 400 127.03 50,812
2019-06-10 Sayer Kevin R (President, CEO and Chairman) Sale 6,000 131.44 788,670
2019-06-05 Balo Andrew K (*) Sale 7,825 125.00 978,125
2019-06-03 Abbey Donald (EVP Quality and Regulatory Aff) Sale 9,030 121.08 1,093,352
2019-05-29 Blackford Quentin S. (EVP Chief Financial Officer) Sale 8,874 119.02 1,056,139
2019-05-23 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 117.25 236,380
2019-05-23 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 3,597 116.88 420,413
2019-05-15 Foletta Mark G (Director) Sale 1,000 121.08 121,085
2019-05-13 Sayer Kevin R (President, CEO and Chairman) Sale 6,000 116.31 697,890
2019-05-10 Murphy Patrick Michael (SVP Legal Affairs) Sale 400 116.92 46,768
2019-04-24 Leach Jacob Steven (EVP Chief Technology Officer) Option Ex 4,797 7.27 34,874
2019-04-23 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 116.92 235,702
2019-04-23 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 3,596 116.74 419,800
2019-04-15 Sayer Kevin R (President, CEO and Chairman) Sale 6,000 118.32 709,914
2019-04-15 Foletta Mark G (Director) Sale 1,000 118.40 118,401
2019-04-10 Murphy Patrick Michael (SVP Legal Affairs) Sale 400 115.05 46,020
2019-04-01 Altman Steven R (Director) Sale 2,500 119.60 299,000
2019-03-25 Doubleday Richard (EVP Chief Commercial Officer) Sale 2,016 127.12 256,277
2019-03-22 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 3,596 140.16 504,026
2019-03-15 Foletta Mark G (Director) Sale 1,000 149.96 149,962
2019-03-12 Leach Jacob Steven (EVP Chief Technology Officer) Sale 8,555 142.79 1,221,585
2019-03-12 Murphy Patrick Michael (SVP Legal Affairs) Sale 3,962 142.79 565,741
2019-03-12 Blackford Quentin S. (EVP Chief Financial Officer) Sale 5,358 142.79 765,079
2019-03-12 Ace Heather S (SVP Human Resources) Sale 5,793 142.79 827,194
2019-03-12 Abbey Donald (EVP Quality and Regulatory Aff) Sale 7,653 142.79 1,092,787
2019-03-12 Doubleday Richard (EVP Chief Commercial Officer) Sale 10,811 142.79 1,543,724
2019-03-12 Moy Jeffrey (SVP Operations) Sale 8,531 142.79 1,218,158
2019-03-12 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 10,811 142.79 1,543,724
2019-03-12 Balo Andrew K (*) Sale 10,917 142.79 1,558,860
2019-03-12 Sayer Kevin R (President, CEO and Chairman) Sale 26,566 142.79 3,793,412
2019-03-11 Ace Heather S (SVP Human Resources) Sale 4,668 143.41 669,456
2019-03-11 Sayer Kevin R (President, CEO and Chairman) Sale 6,000 143.10 858,629
2019-03-08 Murphy Patrick Michael (SVP Legal Affairs) Sale 400 141.56 56,624
2019-02-22 Pacelli Steven Robert (EVP Strategy and Corporate Dev) Sale 5,001 145.71 728,685
2019-02-15 Foletta Mark G (Director) Sale 1,000 149.02 149,022
2019-02-11 Sayer Kevin R (President, CEO and Chairman) Sale 6,000 149.19 895,170
2019-02-08 Murphy Patrick Michael (SVP Legal Affairs) Sale 800 142.76 114,208
2019-01-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 149.74 466,302
2019-01-14 Kahn Barbara (Director) Sale 10,631 142.02 1,509,803
2019-01-14 Sayer Kevin R (President, CEO & Chairman) Sale 6,000 141.15 846,882
2019-01-10 Murphy Patrick Michael (SVP, GC & Chief Compliance Officer) Sale 400 138.75 55,500
2019-01-02 Skyler Jay S (Director) Option Ex 25,806 4.58 118,191
2019-01-02 Altman Steven R (Director) Sale 2,500 117.04 292,592
2018-12-21 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,510 109.47 165,296
2018-12-21 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 109.59 341,278
2018-12-14 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,000 120.80 604,020
2018-12-10 Murphy Patrick Michael (SVP, GC & Chief Compliance Officer) Sale 400 121.90 48,760
2018-12-10 Sayer Kevin R (President, CEO & Chairman) Sale 11,162 121.91 1,360,714
2018-12-10 Sayer Kevin R (President, CEO & Chairman) Option Ex 11,162 4.58 51,121
2018-11-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,736 120.87 209,830
2018-11-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 121.19 377,382
2018-11-14 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,000 142.92 714,610
2018-11-12 Sayer Kevin R (President, CEO & Chairman) Sale 11,161 145.73 1,626,514
2018-11-12 Sayer Kevin R (President, CEO & Chairman) Option Ex 11,161 4.58 51,117
2018-11-09 Murphy Patrick Michael (SVP, GC & Chief Compliance Officer) Sale 400 148.11 59,244
2018-11-09 Ace Heather S (SVP Human Resources) Sale 4,258 148.00 630,162
2018-11-09 Abbey Donald (EVP, Quality & Regulatory Afrs) Sale 10,550 148.73 1,569,112
2018-10-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,736 129.22 224,325
2018-10-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 128.96 401,568
2018-10-12 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,000 124.86 624,300
2018-10-10 Murphy Patrick Michael (SVP, GC & Chief Compliance Officer) Sale 400 122.20 48,880
2018-10-08 Sayer Kevin R (President, CEO & Chairman) Sale 11,161 124.88 1,393,819
2018-10-08 Sayer Kevin R (President, CEO & Chairman) Option Ex 11,161 4.58 51,117
2018-10-01 Altman Steven R (Director) Sale 2,500 136.73 341,830
2018-09-28 Leach Jacob Steven (Chief Technology Officer) Sale 47,600 143.72 6,841,310
2018-09-24 Doubleday Richard (EVP, Chief Commercial Officer) Sale 1,736 140.61 244,102
2018-09-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 140.99 439,036
2018-09-14 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,000 144.86 724,320
2018-09-12 Leach Jacob Steven (SVP, Research & Development) Option Ex 15,000 5.92 88,800
2018-09-11 Blackford Quentin S. (EVP, CFO, PFO & PAO) Sale 8,440 146.75 1,238,578
2018-09-10 Leach Jacob Steven (SVP, Research & Development) Sale 4,614 143.75 663,285
2018-09-10 Murphy Patrick Michael (VP, Legal Aff & Chf Compl Ofcr) Sale 2,372 143.62 340,666
2018-09-10 Blackford Quentin S. (EVP, CFO, PFO & PAO) Sale 7,149 143.75 1,027,704
2018-09-10 Ace Heather S (SVP Human Resources) Sale 1,832 143.75 263,359
2018-09-10 Abbey Donald (EVP, Quality & Regulatory Afrs) Sale 2,303 143.75 331,067
2018-09-10 Doubleday Richard (EVP, Chief Commercial Officer) Sale 5,483 143.75 788,208
2018-09-10 Moy Jeffrey (SVP, Operations) Sale 10,330 143.62 1,483,594
2018-09-10 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 5,483 143.75 788,208
2018-09-10 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,587 143.75 803,159
2018-09-10 Sayer Kevin R (President, CEO & Chairman) Sale 25,495 143.44 3,657,079
2018-09-10 Sayer Kevin R (President, CEO & Chairman) Option Ex 11,161 4.58 51,117
2018-08-24 Leach Jacob Steven (SVP, Research & Development) Sale 20,577 138.32 2,846,148
2018-08-24 Leach Jacob Steven (SVP, Research & Development) Option Ex 20,577 4.55 93,728
2018-08-24 Foletta Mark G (Director) Sale 1,000 137.50 137,503
2018-08-24 Altman Steven R (Director) Sale 5,000 136.47 682,360
2018-08-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 2,584 141.11 364,638
2018-08-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 141.10 439,382
2018-08-14 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,000 124.56 622,805
2018-08-13 Sayer Kevin R (President, CEO & Chairman) Sale 11,161 123.43 1,377,613
2018-08-13 Sayer Kevin R (President, CEO & Chairman) Option Ex 11,161 4.58 51,117
2018-08-10 Murphy Patrick Michael (VP, Legal Aff & Chf Compl Ofcr) Sale 12,500 123.74 1,546,750
2018-08-06 Augustinos Nicholas (Director) Sale 12,300 121.47 1,494,031
2018-08-01 Moy Jeffrey (SVP, Operations) Sale 5,831 94.13 548,872
2018-07-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 3,114 101.94 317,428
2018-07-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 2,581 102.81 265,347
2018-07-16 Balo Andrew K (EVP, Reg. Strategy, Clinical) Sale 5,000 99.92 499,590
2018-07-16 Gregg Terrance H (Executive Chairman) Sale 10,000 99.94 999,440
2018-07-09 Sayer Kevin R (President & CEO) Sale 14,219 99.86 1,419,909
2018-06-28 Moy Jeffrey (SVP, Operations) Sale 59,193 92.29 5,462,744
2018-06-25 Doubleday Richard (EVP, Chief Commercial Officer) Sale 2,581 98.58 254,432
2018-06-15 Gregg Terrance H (Executive Chairman) Sale 10,000 97.81 978,100
2018-06-12 Topol Eric (Director) Sale 20,000 100.10 2,002,000
2018-05-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 2,581 86.00 221,963
2018-05-15 Gregg Terrance H (Executive Chairman) Sale 10,000 85.90 858,970
2018-05-14 Skyler Jay S (Director) Sale 30,000 88.00 2,640,000
2018-05-14 Skyler Jay S (Director) Option Ex 30,000 4.58 137,400
2018-05-10 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 2,855 7.63 21,783
2018-05-09 Leach Jacob Steven (SVP, Research & Development) Sale 8,745 84.77 741,331
2018-05-09 Leach Jacob Steven (SVP, Research & Development) Option Ex 8,745 8.53 74,551
2018-05-09 Sayer Kevin R (President & CEO) Sale 17,245 84.37 1,454,995
2018-05-09 Sayer Kevin R (President & CEO) Option Ex 31,464 7.63 240,070
2018-05-08 Leach Jacob Steven (SVP, Research & Development) Sale 4,423 85.05 376,184
2018-05-08 Leach Jacob Steven (SVP, Research & Development) Option Ex 1,923 3.19 6,134
2018-05-08 Skyler Jay S (Director) Sale 31,464 85.11 2,678,026
2018-05-08 Skyler Jay S (Director) Option Ex 31,464 7.63 240,070
2018-04-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 2,581 73.09 188,650
2018-04-16 Gregg Terrance H (Executive Chairman) Sale 10,000 73.04 730,410

Insider trading activities including stock purchases, stock sales, and option exercises of DXCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dexcom Inc (symbol DXCM, CIK number 1093557) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month